Glutaminergic Agents for Cocaine Abuse - 5

Phase 1

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000280
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-09
• Primary Completion: 1999-08
• Study Completion: 1999-08
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2002-12
• Last Update Submitted: 2017-04-21
• Last Update Posted: 2017-04-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cocaine effects

Trial Locations

Locations (1)

VA Connecticut Healthcare System; 🇺🇸 New Haven, Connecticut, United States